Target intelligence / Profile preview

Meleagrid alphaherpesvirus 1 entry receptors (HVT receptors)

Target
HVT receptors
Molecular classification
Receptor, Cell adhesion molecule, Tumor necrosis factor receptor superfamily member, Glycoprotein
01

Overview

The host cell entry receptors for the Meleagrid alphaherpesvirus 1 (Herpesvirus of Turkeys, HVT) viral vector are the cellular proteins that facilitate the attachment and internalization of the virus into avian host cells. HVT is a non-pathogenic alphaherpesvirus widely utilized as a recombinant viral vector in poultry vaccines to protect against diseases such as Marek's disease, Newcastle disease, and Avian Influenza (Afonso et al., 2001, Journal of Virology). The entry process involves a multi-step cascade starting with the binding of viral glycoproteins, such as gC or gB, to cell-surface heparan sulfate proteoglycans for initial attachment. This is followed by the specific interaction of viral glycoprotein D (gD) with host receptors, primarily Nectin-1 (Poliovirus receptor-related 1) and potentially the Herpesvirus Entry Mediator (HVEM), which triggers membrane fusion mediated by the gB and gH/gL complex (Geraghty et al., 1998, Science; Spear, 2004, Cellular Microbiology). These receptors are predominantly expressed on lymphoid and epithelial cells, determining the vector's tissue tropism and its ability to establish a persistent, non-pathogenic infection that confers long-term immunity (Bublot & Sharma, 2004, Revue Scientifique et Technique). In biotechnology, these receptors are targeted to optimize the delivery of foreign antigens and to ensure the safety and efficacy of recombinant HVT-based vaccines.

Other names
Herpesvirus of turkeys receptorsHVT entry mediatorsAvian Nectin-1Avian HVEMTurkey herpesvirus entry receptors
02

Mechanism of action

Viral envelope fusion with the host cell membrane mediated by the sequential binding of viral glycoproteins to heparan sulfate proteoglycans and specific protein receptors like Nectin-1 and HVEM.

03

Biological functions

Viral entryCell-to-cell spreadMembrane fusionCell-cell adhesion
04

Disease associations

Marek's diseaseInfectionAvian influenzaNewcastle disease
05

Safety considerations

Recombination with virulent Marek's disease virus strainsVector persistence in host tissuesPotential for altered host range
06

Interacting drugs

Vaxxitek HVT+IBD

4 more in the full profile.

07

Biomarkers

Nectin-1 expression levelHVEM expression levelHeparan sulfate density

Beyond the preview

Go deeper on Meleagrid alphaherpesvirus 1 entry receptors (HVT receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meleagrid alphaherpesvirus 1 entry receptors (HVT receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call